Back to search

Article

Rare damaging <i>CCR2</i> variants are associated with lower lifetime cardiovascular risk

2023-08-16

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Previous work has shown a role of CCL2, a key chemokine governing monocyte trafficking, in atherosclerosis. However, it remains unknown whether targeting CCR2, the cognate receptor of CCL2, provides protection against human atherosclerotic cardiovascular disease. <h4>Methods</h4> Computationally predicted damaging or loss-of-function (REVEL>0.5) variants within CCR2 were d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6628cb7c-9544-575d-a1f3-607e6106d3e9
DOI
10.1101/2023.08.14.23294063
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Rare damaging <i>CCR2</i> variants are associated with lower lifetime cardiovascular riskDOI 10.1101/2023.08.14.23294063
Select a neighboring publication to make it the new centre.